A retrospective review of primary prophylaxis with granulocyte-colony stimulating factor (G-CSF) for patients with genitourinary malignancies receiving chemotherapy during the COVID-19 pandemic and implications for the future.

Authors

null

Nely Mercy Diaz Mejia

Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON., Toronto, ON, Canada

Nely Mercy Diaz Mejia , Carlos Stecca , Di Maria Jiang , Nazanin Fallah-Rad , Philippe L. Bedard , Vikaash Kumar , Osama Abdeljalil , Amer Zahralliyali , Husam Alqaisi , Esmail Mutahar Al-Ezzi , Vivian Choy , Parmvir Banwait , Eshetu Atenafu , Srikala S. Sridhar

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Prostate Cancer

Track

Prostate Cancer - Advanced,Prostate Cancer - Localized

Sub Track

Quality of Care/Quality Improvement and Real-World Evidence

Citation

J Clin Oncol 41, 2023 (suppl 6; abstr 115)

DOI

10.1200/JCO.2023.41.6_suppl.115

Abstract #

115

Poster Bd #

D8

Abstract Disclosures